[Effect of Shexiang Baoxin pill on coronary vasodilation by analysis of coronary angiography]

Insights

Shexiang Baoxin Pill (SBP) effectively dilates coronary arteries in patients with normal or stenotic coronary angiography (CAG) findings. This traditional Chinese medicine treatment does not significantly affect heart rate or blood pressure.

Area of Science:

  • Cardiology
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Vasodilation is a critical factor in improving coronary blood flow.
  • Shexiang Baoxin Pill (SBP) is a traditional Chinese medicine used for cardiovascular conditions.

Purpose of the Study:

  • To investigate the effect of Shexiang Baoxin Pill (SBP) on coronary vasodilation.
  • To analyze changes in coronary artery diameter using coronary angiography (CAG).

Main Methods:

  • A randomized controlled trial involving 300 patients undergoing CAG.
  • Patients received either SBP or placebo sublingually before CAG.
  • Quantitative angiography analysis measured coronary artery diameters before and after administration.

Main Results:

  • SBP significantly increased coronary artery diameter in both normal and stenotic arteries (P < 0.01).
  • No significant changes in heart rate, systolic, or diastolic blood pressure were observed.
  • SBP demonstrated superior vasodilation compared to placebo (P < 0.05, P < 0.01).

Conclusions:

  • Shexiang Baoxin Pill (SBP) effectively induces coronary vasodilation.
  • SBP is safe for cardiovascular function, showing no adverse effects on heart rate or blood pressure.
  • SBP shows potential as a therapeutic agent for improving coronary blood flow.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.9K
Antianginal Drugs: Nitrates and &#946;-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
2.0K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
455